CEMEX, S.A.B. de C.V. enters May having outperformed its global cement peers by a wide margin, with a strong Q1 earnings print behind it and the Street steadily moving targets higher — a notably different setup from the macro noise weighing on the broader sector.
The price action tells the story clearly. CX closed at $12.13 on Tuesday, up nearly 13% on the month and up about 3% on the week — gains that stand out against a sector backdrop where most correlated names lost ground. CRH fell 5.7% on the week, Vulcan Materials slipped 1.3%, and Argentine peer Loma Negra dropped 8.7%. The outperformance followed CEMEX's Q1 2026 earnings call on April 23, where the stock jumped 5%, its best single-day reaction in recent memory.
Options positioning reinforces the bullish tone. The put/call ratio has compressed sharply to 0.23 this week — more than one standard deviation below its 20-day average of 0.31 — hitting what amounts to the most call-heavy reading in months. Earlier in April, the PCR was running above 0.35; the drop mirrors almost exactly the moment earnings results hit. That said, the 14-day RSI is now at 56.8, not stretched, so the technical setup has room to breathe without looking overbought.
Short positioning is restrained and not a meaningful driver here. Borrowing costs are modest at 0.52% annually, and availability remains deep — far from the kind of lending tightness that precedes short squeezes. The short score of 28.3 ranks in the 90th percentile of the universe for being uncrowded, meaning there is no material short overhang to worry about. Estimated shares short did tick up about 2.4% on the week, but from a low base, and the 1.2-day days-to-cover reading confirms there is no positional stress in the borrow market.
Analyst upgrades have accumulated over the past several weeks and the direction of travel is unambiguously higher. JP Morgan maintained Overweight and raised its target to $14.50 on April 24, a move that followed the Q1 print directly. Morgan Stanley upgraded CEMEX to Overweight in late March. Scotiabank has raised its target three times since February, moving from $11.10 to $14.10. The mean price target is now $14.13 — roughly 16.5% above the current price — and even Barclays, which held its Overweight in October, has lifted targets since then. The bull case centres on CEMEX's FCF conversion improvement (projected at ~33% in 2025 versus 28% in 2019) and leverage reduction, with adjusted net debt/EBITDA falling from 5.1x in 2019 to a projected 2.5x by 2025. Bears point to persistently weak business confidence in Mexico, which accounts for roughly 40% of EBITDA, ongoing constitutional reform risk, and a planned $400M capex reduction that could constrain long-term operational capacity. Valuation is undemanding on a P/E basis at 14.6x, with the price/book at 1.2x — multiples that have expanded modestly over the month as sentiment has improved.
Institutionally, Boston Partners initiated a substantial new position, with reported holdings jumping by nearly 190 million shares in the most recently filed data — one of the larger single-quarter institutional additions in the name. BlackRock, Dodge & Cox, and Vanguard all added modestly in Q1. Insider activity is also worth flagging: David Martinez Guzman, a long-standing figure in CEMEX's capital structure, appears in the institutional filings with 234 million shares newly reported as of mid-March.
The next earnings event is scheduled for July 23. Between now and then, the watch items are the trajectory of Mexican cement demand against the reform-driven investment backdrop, any fresh guidance on FCF conversion targets, and whether the elevated call-side options positioning this week signals front-running of further analyst upgrades — or simply post-earnings relief buying that fades as the stock approaches consensus targets near $14.
See the live data behind this article on ORTEX.
Open CX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
